KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $4.0 billion.

  • Oscar Health's Cash & Current Investments rose 8546.78% to $4.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.0 billion, marking a year-over-year increase of 8546.78%. This contributed to the annual value of $4.0 billion for FY2025, which is 8546.78% up from last year.
  • Latest data reveals that Oscar Health reported Cash & Current Investments of $4.0 billion as of Q4 2025, which was up 8546.78% from $3.0 billion recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Cash & Current Investments registered a high of $4.0 billion during Q4 2025, and its lowest value of $1.7 billion during Q3 2021.
  • Over the past 5 years, Oscar Health's median Cash & Current Investments value was $2.8 billion (recorded in 2022), while the average stood at $2.8 billion.
  • Per our database at Business Quant, Oscar Health's Cash & Current Investments surged by 45119.84% in 2021 and then plummeted by 3004.24% in 2024.
  • Quarter analysis of 5 years shows Oscar Health's Cash & Current Investments stood at $1.7 billion in 2021, then surged by 74.79% to $3.0 billion in 2022, then decreased by 13.39% to $2.6 billion in 2023, then decreased by 15.96% to $2.2 billion in 2024, then soared by 85.47% to $4.0 billion in 2025.
  • Its last three reported values are $4.0 billion in Q4 2025, $3.0 billion for Q3 2025, and $3.5 billion during Q2 2025.